Abstract
A regioselective, mild, convenient, and effective condition is
developed for the inclusion of glyoxylic acid as formaldehyde equivalent
in the 3CC reaction towards synthesis of 3-aminoalkyl imidazo-azines.
In general, formaldehydes do not perform well with Ugi-type multicomponent
sequences, and the method reported here is a regioselective and
high-yielding one for the HCHO variant of Groebke-Blackburn-Bienaymé reaction.
Key words
Groebke-Blackburn-Bienaymé - multicomponent reaction - aminoimidazoazines - formaldehyde - glyoxylic
acid
References and Notes
1a
Groebke K.
Weber L.
Mehlin F.
Synlett
1998,
661
1b
Bienaymé H.
Bouzid K.
Angew. Chem.
Int. Ed.
1998,
37:
2234
1c
Blackburn C.
Guan B.
Fleming P.
Shiosaki K.
Tsai S.
Tetrahedron
Lett.
1998,
39:
3635
2a
Varma RS.
Kumar D.
Tetrahedron
Lett.
1999,
40:
7665
2b
Chen JJ.
Golebiowski A.
McClenaghan J.
Klopfenstein SR.
West L.
Tetrahedron Lett.
2001,
42:
2269
2c
Lu Y.
Zhang W.
QSAR Comb. Sci.
2004,
23:
827
2d
Gudmundsson KS.
Masquelin T.
Perun T.
Hulme C.
Tetrahedron
Lett.
2005,
46:
8355
2e
Mironov MA.
Tokareva MI.
Ivantsova MN.
Mokruskin VS.
Russ.
Chem. Bull. Int. Ed.
2006,
55:
1835
2f
Parchinsky VZ.
Schuvalova O.
Ushalova O.
Krachenko DV.
Krasavin M.
Tetrahedron Lett.
2006,
47:
947
2g
Masquelin T.
Baui H.
Brickley B.
Stephenson G.
Schwerkoske J.
Hulme C.
Tetrahedron Lett.
2006,
47:
2989
2h
Che C.
Xiang J.
Wang G.-X.
Fathi R.
Quan J.-M.
Yang Z.
J. Comb. Chem.
2007,
9:
982
2i
Shaabani A.
Soleeimani E.
Maleki A.
Monatsh.
Chem.
2007,
138:
73
2j
DiMauro EF.
Kennedy JM.
J.
Org. Chem.
2007,
72:
1013
2k
Nenadjenko VG.
Reznichenko AL.
Balenkova ES.
Russ. Chem. Bull.
Int. Ed.
2007,
56:
560
2l
Umkehrer M.
Ross G.
Jager N.
Burdack C.
Kolb J.
Hu H.
Alvim-Gaston M.
Hulme C.
Tetrahedron
Lett.
2007,
48:
2213
2m
Rousseau AL.
Matlaba P.
Parkinson CJ.
Tetrahedron Lett.
2007,
48:
4079
2n
Adib M.
Madhavi M.
Noghani MA.
Mirzaei P.
Tetrahedron Lett.
2007,
48:
7263
2o
Guchhait SK.
Madaan C.
Synlett
2009,
628
3a
Sablayrolles C.
Cros GH.
Milhavet JC.
Rechenq E.
Chapat J.-P.
Boucard M.
Serrano JJ.
McNeill JH.
J. Med. Chem.
1984,
27:
206
3b
Kaminski JJ.
Bristol
JA.
Puchalski C.
Lovey RG.
Elliott AJ.
Guzik H.
Solomon DM.
Conn DJ.
Domalski MS.
Wong SC.
Gold EH.
Long JF.
Chiu PJS.
Steinberg M.
Mc Phail AT.
J. Med. Chem.
1985,
28:
876
3c
Clements-Jewery S.
Danswan G.
Gardner CR.
Matharu SS.
Murdoch R.
Tully WR.
Westwood R.
J. Med. Chem.
1988,
31:
1220
3d
Kaminski JJ.
Wallmark B.
Briving C.
Andersson B.-M.
J.
Med. Chem.
1991,
34:
533
3e
Rival Y.
Grassy G.
Michel G.
Chem.
Pharm. Bull.
1992,
40:
1170
3f
Meurer L.
Tolman RL.
Chapin EW.
Saperstein R.
Vicario PP.
Zrada M.
MacCoss
MM.
J. Med. Chem.
1992,
35:
3845
3g
Lober S.
Hubner H.
Gmeiner P.
Bioorg.
Med. Chem. Lett.
1999,
9:
97
3h
Lhassani M.
Chavignon O.
Chezal J.-M.
Teulade J.-C.
Chapat J.-P.
Snoeck R.
Andrei G.
Balzarini J.
De Clerque E.
Gueiffier A.
Eur. J. Med. Chem.
1999,
271
3i
Hamdouchi C.
de Blas J.
del Prado M.
Gruber J.
Heinz BA.
Vance L.
J. Med. Chem.
1999,
42:
50
3j
Trapini G.
Franco M.
Latrofa A.
Ricciardi L.
Carotti A.
Serra M.
Sanna E.
Biggio G.
Liso G.
J. Med. Chem.
1999,
42:
3934
3k
Warshakoon NC.
Wu S.
Boyer A.
Kawamoto R.
Sheville J.
Renock S.
Xu K.
Pokross M.
Evdokimov AG.
Walter R.
Mekel M.
Bioorg. Med.
Chem. Lett.
2006,
16:
5598
4a
Georges G.
Vercauteren DP.
Vanderveken DJ.
Horion R.
Evrard GH.
Durant FV.
George P.
Wick AE.
Eur. J. Med. Chem.
1993,
323
4b
Jain AK.
J. Med. Chem.
2004,
47:
947
4c
Swainston Harrison T.
Keating GM.
CNS
Drugs
2005,
19:
65
4d
Wiegand MH.
Drugs
2008,
68:
2411
4e
Hanson SM.
Morlock EV.
Satyshur KA.
Czajkowski C.
J.
Med. Chem.
2008,
51:
7243
4f
Chernyak N.
Gevorgyan V.
Angew. Chem. Int. Ed.
2010,
49:
2743
5
Li HY.
McMillen T.
Heap CR.
McCann DJ.
Yan L.
Campbell RM.
Mundla SR.
King CR.
Dierks EA.
Anderson BD.
Britt KS.
Huss KL.
Voss MD.
Wang Y.
Clawson DK.
Yingling JM.
Sawyer JS.
J.
Med. Chem.
2008,
51:
2302
6a
Wu Z.
Fraley ME.
Bilodeau MT.
Kaufman ML.
Tasber ES.
Balitza AE.
Hartman GD.
Coll KE.
Rickert K.
Shipman J.
Shi B.
Sepp-Lerenzino L.
Thomas KA.
Bioorg.
Med. Chem.
2004,
14:
909
6b
Breitenbucher GJ.
Tichenor MS.
Merit JE.
Hawryluk NA.
Chambers AL.
Keith JM.
,
7a
Hulme C.
Gore V.
Curr.
Med. Chem.
2003,
10:
51
7b
Hulme C.
Nixey T.
Curr. Opin. Drug Discovery Dev.
2003,
6:
921
7c
Dömling A.
Chem. Rev.
2006,
106:
17
7d
Rivera DG.
Pando O.
Coll F.
Tetrahedron
2006,
62:
8327
7e
Rivera DG.
Wessjohann LA.
Molecules
2007,
12:
1890
7f
Banfi L.
Basso A.
Cerulli V.
Guanti G.
Riva R.
J.
Org. Chem.
2008,
73:
1608
7g
Hulme C.
Lee Y.-S.
Mol. Diversity
2008,
12:
1
7h
Banfi L.
Riva R.
Basso A.
Synlett
2010,
23
7i
Nichol GS.
Sharma A.
Li H.-Y.
Acta
Crystallogr.
2011,
E67:
o833
8a
Sisko J.
Kassik AJ.
Mellinger M.
Filan JJ.
Allen A.
Olsen MA.
J.
Org. Chem.
2000,
65:
1516
8b
Lyon MA.
Kercher TS.
Org.
Lett.
2004,
6:
4989
9a
Kaminski JJ.
Hilbert JM.
Pramanik BN.
Solomon DM.
Conn DJ.
Rizvi RK.
Elliott AJ.
Guzik H.
Lovey RG.
Domalski MS.
Wong S.-C.
Puchalski C.
Gold EH.
Long JF.
Chiu PJS.
McPhailt AT.
J. Med. Chem.
1987,
30:
2031
9b
Groziak MP.
Wilson SR.
Clauson GL.
Leonard NJ.
J.
Am. Chem. Soc.
1986,
108:
8002
9c
Katritzky AR.
Xu Y.-J.
Tu H.
J.
Org. Chem.
2003,
68:
4935
10
Representative
Procedure for the Synthesis of
N
-(2,6-dimethylphenyl)imidazo[1,2-
a
]pyridin-3-amine
(3b, Table 2)
To a solution of 2-aminopyridine (1b , 1.05 mmol) in MeOH (1.5 mL), was added
glyoxylic acid (1.78 mmol) followed by HClO4 (0.105 mmol),
and the solution was stirred for 10 min. 2-Isocyano-1,3-dimethylbenzene
(1.05 mmol) was added to this mixture, and the solution was stirred
for 12 h. MeOH was evaporated from the reaction mixture, and the crude
was purified through silica gel chromatography to provide 3b in 77% yield. ¹ H
NMR (400 MHz, DMSO-d
6 ): δ = 8.72
(d, J = 8
Hz, 1 H), 7.81 (d, J = 4
Hz, 2 H), 7.60 (s, 1 H), 7.52-7.48 (m, 1 H), 7.11 (d, J = 8 Hz,
2 H), 7.05-7.02 (m, 3 H), 2.09 (s, 6 H). ¹³ C
NMR (400 MHz, DMSO-d
6 ): δ = 138.5,
136.4, 135.8, 133.4, 132.0, 131.7, 129.3, 128.0, 125.8, 125.3, 116.6,
112.9, 106.3, 18.1. HRMS: m/z calcd
for C15 H16 N3 : 238.13387; found:
238.13377. LC-MS (ES): 98.6% (λ = 214
nm).
11 Formation of regioisomer was observed
during optimization studies using paraformaldehyde as formaldehyde
source (entry 8, Table
[¹ ]
).
12
Mandair GS.
Light M.
Russell A.
Hursthouse M.
Bradley M.
Tetrahedron
Lett.
2002,
43:
4267
13 Nichol, G. S.; Sharma, A.; Li, H.
Y. unpublished results .